IBAC IB Acquisition Corp. NASDAQ · United States

IB Acquisition (IBAC) news

IB Acquisition Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IBAC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest IB Acquisition news

We have not published a story on IB Acquisition yet. When there is news, it will appear here.

IB Acquisition annual financials

Line	FY ended Sep 30, 2025	FY ended Sep 30, 2024
Net income (loss)	$3.4 million	$1.9 million
Cash from operations	-$1.3 million	-$820,959
Cash and equivalents	$428,700	$822,799

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $30,161.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about IB Acquisition

What is the ticker symbol of IB Acquisition?

IB Acquisition Corp. trades under the ticker IBAC on NASDAQ.

Where is IB Acquisition listed?

IB Acquisition Corp. is listed on NASDAQ.

Which country or territory is IB Acquisition listed under?

Our directory records IB Acquisition Corp. under United States.

Does aibio.space cover IB Acquisition?

aibio.space lists IB Acquisition Corp. among 2,820 public biotech companies and publishes its news here as stories appear.

Is IB Acquisition profitable?

IB Acquisition Corp. reported net income of $3.4 million for the fiscal year ended Sep 30, 2025, and used $1.3 million of cash in operations, per its annual report to the SEC.

How much cash does IB Acquisition have?

$30,161 in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: IB Acquisition

Members talk about IB Acquisition (IBAC). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at IB Acquisition, newest first. Each line links the filing it comes from.

Oct 15, 2026Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 5.08,8.01,9.01). Source
Oct 6, 2026Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). Source
Jul 24, 2026Mergers
Filed documents for a merger or acquisition. SEC Form S-4. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:IBAC on TradingView.

Listing details

Company: IB Acquisition Corp.
Ticker: IBAC
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction